Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 199

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 199
---
-276232) and was declared effective by the SEC on January 31, 2024. Between February 5, 2024 and February 13, 2024, the Company has received notices of cash exercise for the Class D Pre-Funded Warrants issued in connection with the February 2024 Public Offering for 77,282shares of common stock at a total purchase price of $ 123.65. As of December 31, 2024, there were noClass D Pre-Funded Warrants outstanding. On August 22, 2024, the Company issued 6,312shares of common stock in connection with a notice of cash exercise for the Class D Common Stock Warrants issued in connection with the February 2024 Public Offering with a total purchase price of $ 241,390. Using the Black-Scholes option pricing model, the Class D Common Stock Warrants were valued in the aggregate at $ 6.3million and was included in the issuance costs of the February 2024 Public Offering and treated as equity (see Note 10). As part of the Class D Warrant Inducement (defined below) the Company issued common stock to a third party consultant on June 11, 2024, as a result the exercise price of the Class D Common Stock Warrants were reset from $ 72.48to $ 38.24. Additionally, on August 22, 2024, the exercise price of the Class D Common Stock Warrants was reset from $ 38.24to $ 16.00. As part of the 2025 Reverse Stock Split on January 28, 2025, the exercise price of the Class D Common Stock Warrants was reset from $ 16.00to $ 3.7596. Class D Warrant Inducement On June 11, 2024, the Company issued 653shares of common stock to a third party consultant in order to induce the holders of the Class D Common Stock Warrants, as a result the exercise price of the Class D Common Stock Warrants were reduced from $ 72.48to $ 38.24. Further, on August 21, 2024, the Company entered into warrant exercise inducement offer letters with certain holders (the “Class D Holders”) of 2,548,060existing Class D Common Stock Warrants exercisable for an aggregate of 159,249shares of its common stock (collectively, the “Class D Common